{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T15:14:03Z","timestamp":1777648443104,"version":"3.51.4"},"reference-count":64,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,23]],"date-time":"2024-03-23T00:00:00Z","timestamp":1711152000000},"content-version":"am","delay-in-days":388,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Therapies"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1016\/j.therap.2022.10.003","type":"journal-article","created":{"date-parts":[[2022,10,8]],"date-time":"2022-10-08T10:43:52Z","timestamp":1665225832000},"page":"201-211","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Increase of cannabis and cocaine use by pregnant women in France from 2005 to 2018: Insights of the annual cross sectional OPPIDUM survey"],"prefix":"10.1016","volume":"78","author":[{"given":"L\u00e9na","family":"Blayac","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Camille","family":"Ponte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monique","family":"Lavaud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jo\u00eblle","family":"Micallef","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maryse","family":"Lapeyre-Mestre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.therap.2022.10.003_bib0325","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1016\/j.jogc.2017.04.028","article-title":"No. 349-substance use in pregnancy","volume":"39","author":"Ordean","year":"2017","journal-title":"J Obstet Gynaecol Can"},{"key":"10.1016\/j.therap.2022.10.003_bib0330","author":"Whittaker","year":"2011"},{"key":"10.1016\/j.therap.2022.10.003_bib0335","unstructured":"World Health Organization. Guidelines for the identification and management of substance use and substance use disorders in pregnancy. Geneva: World Health Organization. 2014. https:\/\/www.who.int\/publications\/i\/item\/9789241548731. [Accessed 26 July 2022]."},{"key":"10.1016\/j.therap.2022.10.003_bib0340","unstructured":"Haute autorit\u00e9 de sant\u00e9. Recommandations professionnelles: suivi et orientation des femmes enceintes en fonction des situations \u00e0 risque identifi\u00e9es. 2016. https:\/\/www.has-sante.fr\/jcms\/c_547976\/fr\/suivi-et-orientation-des-femmes-enceintes-en-fonction-des-situations-a-risque-identifiees. [Accessed 26 July 2022]."},{"key":"10.1016\/j.therap.2022.10.003_bib0345","unstructured":"American College of Obstetricians and Gynecologists. Opioid use and opioid use disorder in Pregnancy. Committee Opinion No. 711. 2017. https:\/\/www.acog.org\/clinical\/clinical-guidance\/committee-opinion\/articles\/2017\/08\/opioid-use-and-opioid-use-disorder-in-pregnancy. [Accessed 26 July 2022]."},{"key":"10.1016\/j.therap.2022.10.003_bib0350","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1097\/NMC.0000000000000160","article-title":"Relational care for perinatal substance use: a systematic review","volume":"40","author":"Kramlich","year":"2015","journal-title":"MCN Am J Matern Child Nurs"},{"key":"10.1016\/j.therap.2022.10.003_bib0355","unstructured":"Observatoire Fran\u00e7ais des Drogues et des Toxicomanies. Drogues et addictions, donn\u00e9es essentielles. 2019. https:\/\/www.ofdt.fr\/publications\/collections\/rapports\/ouvrages-collectifs\/drogues-et-addictions-donnees-essentielles\/. [Accessed 18 October 2022]."},{"key":"10.1016\/j.therap.2022.10.003_bib0360","unstructured":"Substance Abuse and Mental Health Services Administration. National survey on drug use and health: 2020 - Section 1: Illicit drug use\/misuse tables. 2021. https:\/\/www.samhsa.gov\/data\/release\/2020-national-survey-drug-use-and-health-nsduh-releases. [Accessed 26 July 2022]."},{"key":"10.1016\/j.therap.2022.10.003_bib0365","unstructured":"Beck F, Obradovic I, Palle C, Brisacier AC, Cadet-Ta\u00efrou A, D\u00edaz-G\u00f3mez C, et al. Usages de drogues et cons\u00e9quences: quelles sp\u00e9cificit\u00e9s f\u00e9minines? OFDT. 2017. https:\/\/www.ofdt.fr\/publications\/collections\/periodiques\/lettre-tendances\/usages-de-drogues-et-consequences-quelles-specificites-feminines-tendances-n-117-mars-2017\/. [Accessed 18 October 2022]."},{"key":"10.1016\/j.therap.2022.10.003_bib0370","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.drugalcdep.2014.10.003","article-title":"Sex differences in drug use among polysubstance users","volume":"145","author":"Lewis","year":"2014","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.therap.2022.10.003_bib0380","unstructured":"European Monitoring Centre for Drugs and Drug Addiction. European drug report 2021: Trends and developments. Luxembourg: Publications Office of the European Union. 2021. https:\/\/www.emcdda.europa.eu\/publications\/edr\/trends-developments\/2021_en. [Accessed 26 July 2022]."},{"key":"10.1016\/j.therap.2022.10.003_bib0385","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.therap.2019.09.005","article-title":"Safety signal detection by the French Addictovigilance Network: innovative methods of investigation, examples and usefulness for public health","volume":"74","author":"Micallef","year":"2019","journal-title":"Therapie"},{"key":"10.1016\/j.therap.2022.10.003_bib0390","first-page":"243","volume":"54","author":"Thirion","year":"1999","journal-title":"Therapie"},{"key":"10.1016\/j.therap.2022.10.003_bib0395","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1111\/j.1472-8206.2011.00950.x","article-title":"Which psychoactive prescription drugs are illegally obtained and through which ways of acquisition? About OPPIDUM survey: Which psychoactive prescription drugs are illegally obtained?","volume":"26","author":"Frauger","year":"2012","journal-title":"Fundam Clin Pharmacol"},{"key":"10.1016\/j.therap.2022.10.003_bib0400","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1002\/pds.2263","article-title":"Misuse of buprenorphine maintenance treatment since introduction of its generic forms: OPPIDUM survey: misuse of buprenorphine","volume":"21","author":"Nordmann","year":"2012","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.therap.2022.10.003_bib0405","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1111\/fcp.12024","article-title":"OPPIDUM surveillance program: 20 years of information on drug abuse in France","volume":"27","author":"Frauger","year":"2013","journal-title":"Fundam Clin Pharmacol"},{"key":"10.1016\/j.therap.2022.10.003_bib0410","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1111\/fcp.12603","article-title":"Health consequences of cocaine use in France: data from the French Addictovigilance Network","volume":"35","author":"Eiden","year":"2021","journal-title":"Fundam Clin Pharmacol"},{"key":"10.1016\/j.therap.2022.10.003_bib0415","doi-asserted-by":"crossref","first-page":"3789","DOI":"10.1111\/bcp.15323","article-title":"Increase of high-risk tramadol use and harmful consequences in France from 2013-2018: evidence from the triangulation of addictovigilance data","volume":"88","author":"Roussin","year":"2022","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.therap.2022.10.003_bib0420","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1111\/fcp.12346","article-title":"Impact of pregnancy on psychoactive substance use among women with substance use disorders recruited in addiction specialized care centers in France","volume":"32","author":"Pochard","year":"2018","journal-title":"Fundam Clin Pharmacol"},{"key":"10.1016\/j.therap.2022.10.003_bib0425","unstructured":"CEIP-A PACA-Corse, Le R\u00e9seau Fran\u00e7ais d\u2019Addictovigilance. OPPIDUM (Observation des Produits Psychotropes Illicites ou D\u00e9tourn\u00e9s de leur Utilisation M\u00e9dicamenteuse) - R\u00e9sultats de l\u2019enqu\u00eate 30 - Lundi 1er octobre au dimanche 28 Octobre 2018. 2019. https:\/\/ansm.sante.fr\/uploads\/2021\/03\/26\/20210325-oppidum-resultats-enquete-2018.pdf. [Accessed 26 July 2022 (2 pp.)."},{"key":"10.1016\/j.therap.2022.10.003_bib0430","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.encep.2008.12.009","article-title":"\u00c9tat des lieux de la consommation de substances psychoactives par les femmes enceintes","volume":"36","author":"Lamy","year":"2009","journal-title":"L\u2019Enc\u00e9phale"},{"key":"10.1016\/j.therap.2022.10.003_bib0435","unstructured":"Direction de la recherche, des \u00e9tudes, de l\u2019\u00e9valuation et des statistiques (DREES). Enqu\u00eate nationale Rapport 2016 - Les naissances et les \u00e9tablissements. Situation et \u00e9volution depuis 2010. 2017. https:\/\/drees.solidarites-sante.gouv.fr\/publications\/rapports\/enquete-nationale-perinatale-2016-les-naissances-et-les-etablissements. [Accessed 26 July 2022]."},{"key":"10.1016\/j.therap.2022.10.003_bib0440","doi-asserted-by":"crossref","first-page":"106082","DOI":"10.1016\/j.addbeh.2019.106082","article-title":"Cannabis use among women of reproductive age in the United States: 2002-2017","volume":"99","author":"Alshaarawy","year":"2019","journal-title":"Addict Behav"},{"key":"10.1016\/j.therap.2022.10.003_bib0445","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1001\/jama.2019.7982","article-title":"Self-reported medical and nonmedical cannabis use among pregnant women in the United States","volume":"322","author":"Volkow","year":"2019","journal-title":"JAMA"},{"key":"10.1016\/j.therap.2022.10.003_bib0450","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.15585\/mmwr.mm6932a2","article-title":"Characteristics of marijuana use during pregnancy - Eight states, pregnancy risk assessment monitoring system, 2017","volume":"69","author":"Ko","year":"2020","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.therap.2022.10.003_bib0455","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1001\/jama.2021.16328","article-title":"Rates of prenatal cannabis use among pregnant women before and during the COVID-19 Pandemic","volume":"326","author":"Young-Wolff","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/j.therap.2022.10.003_bib0460","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.therap.2020.06.006","article-title":"Addictovigilance contribution during COVID-19 epidemic and lockdown in France","volume":"75","author":"Lapeyre-Mestre","year":"2020","journal-title":"Therapies"},{"key":"10.1016\/j.therap.2022.10.003_bib0465","doi-asserted-by":"crossref","first-page":"76","DOI":"10.17269\/s41997-018-0148-0","article-title":"Trends and correlates of cannabis use in pregnancy: a population-based study in Ontario, Canada from 2012 to 2017","volume":"110","author":"Corsi","year":"2019","journal-title":"Can J Public Health"},{"key":"10.1016\/j.therap.2022.10.003_bib0470","unstructured":"Canada H. Canadian alcohol and drugs survey (CADS): 2019 detailed tables. 2021. https:\/\/www.canada.ca\/en\/health-canada\/services\/canadian-alcohol-drugs-survey\/2019-summary.html. [Accessed 26 July 2022]."},{"key":"10.1016\/j.therap.2022.10.003_bib0475","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.drugalcdep.2018.11.028","article-title":"Beliefs and attitudes regarding prenatal marijuana use: perspectives of pregnant women who report use","volume":"196","author":"Chang","year":"2019","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.therap.2022.10.003_bib0480","first-page":"131","article-title":"Drogues: perceptions des produits, des politiques publiques et des usagers","author":"Spilka","year":"2019","journal-title":"Tendances"},{"key":"10.1016\/j.therap.2022.10.003_bib641","unstructured":"Agence Nationale de Securit\u00e9 du M\u00e9dicament et des produits de sant\u00e9. Augmentation du nombre d\u2019intoxications au cannabis par ingestion accidentelle chez les enfants. 2018. https:\/\/ansm.sante.fr\/actualites\/augmentation-du-nombre-dintoxications-au-cannabis-par-ingestion-accidentelle-chez-les-enfants. [Accessed 18 October 2022]."},{"key":"10.1016\/j.therap.2022.10.003_bib0485","doi-asserted-by":"crossref","first-page":"3925","DOI":"10.1111\/bcp.14812","article-title":"Adverse events of recreational cannabis use reported to the French addictovigilance network (2012-2017)","volume":"87","author":"Bouquet","year":"2021","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.therap.2022.10.003_bib0490","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.ajog.2016.05.044","article-title":"Marijuana use and its effects in pregnancy","volume":"215","author":"Chabarria","year":"2016","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.therap.2022.10.003_bib0495","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1097\/AOG.0000000000001649","article-title":"Maternal marijuana use and adverse neonatal outcomes","volume":"128","author":"Conner","year":"2016","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.therap.2022.10.003_bib0500","doi-asserted-by":"crossref","first-page":"e009986","DOI":"10.1136\/bmjopen-2015-009986","article-title":"Prenatal exposure to cannabis and maternal and child health outcomes: a systematic review and meta-analysis","volume":"6","author":"Gunn","year":"2016","journal-title":"BMJ Open"},{"key":"10.1016\/j.therap.2022.10.003_bib0505","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.jpeds.2018.02.005","article-title":"Cannabis use during the perinatal period in a state with legalized recreational and medical marijuana: the association between maternal characteristics, breastfeeding patterns, and neonatal outcomes","volume":"197","author":"Crume","year":"2018","journal-title":"J Pediatr"},{"key":"10.1016\/j.therap.2022.10.003_bib0510","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1001\/jama.2019.8734","article-title":"Association between self-reported prenatal cannabis use and maternal, perinatal, and neonatal outcomes","volume":"322","author":"Corsi","year":"2019","journal-title":"JAMA"},{"key":"10.1016\/j.therap.2022.10.003_bib0515","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1186\/s12884-020-03371-3","article-title":"Association between maternal cannabis use and birth outcomes: an observational study","volume":"20","author":"Michalski","year":"2020","journal-title":"BMC Pregnancy Childbirth"},{"key":"10.1016\/j.therap.2022.10.003_bib0520","doi-asserted-by":"crossref","first-page":"e195","DOI":"10.1097\/ADM.0000000000000638","article-title":"Canadian cannabis consumption and patterns of congenital anomalies: an ecological geospatial analysis","volume":"14","author":"Reece","year":"2020","journal-title":"J Addict Med"},{"key":"10.1016\/j.therap.2022.10.003_bib0525","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0002-9378(84)80103-9","article-title":"Marijuana use during pregnancy and decreased length of gestation","volume":"150","author":"Fried","year":"1984","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.therap.2022.10.003_bib0530","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/0892-0362(92)90051-B","article-title":"The effects of prenatal tobacco and marijuana use on offspring growth from birth through 3 years of age","volume":"14","author":"Day","year":"1992","journal-title":"Neurotoxicol Teratol"},{"key":"10.1016\/j.therap.2022.10.003_bib0535","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1097\/CHI.0b013e3181bfa8ee","article-title":"Intrauterine cannabis exposure affects fetal growth trajectories: the Generation R Study","volume":"48","author":"El Marroun","year":"2009","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.therap.2022.10.003_bib0540","unstructured":"Renard J, Konefal S. Clearing the smoke on cannabis maternal cannabis use during pregnancy - an update 2. Canadian Centre on Substance Use and Addiction. 2022. https:\/\/ccsa.ca\/sites\/default\/files\/2022-05\/CCSA-Cannabis-Use-Pregnancy-Breastfeeding-Report-2022-en.pdf. [Accessed 26 July 2022 (23 pp.)]."},{"key":"10.1016\/j.therap.2022.10.003_bib0545","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s00213-010-1892-x","article-title":"Developmental consequences of perinatal cannabis exposure: behavioral and neuroendocrine effects in adult rodents","volume":"214","author":"Campolongo","year":"2011","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.therap.2022.10.003_bib0550","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.tcm.2014.12.013","article-title":"Cardiovascular consequences of cocaine use","volume":"25","author":"Stankowski","year":"2015","journal-title":"Trends Cardiovasc Med"},{"key":"10.1016\/j.therap.2022.10.003_bib0555","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1097\/GRF.0b013e31827ae167","article-title":"The maternal, fetal, and neonatal effects of cocaine exposure in pregnancy","volume":"56","author":"Cain","year":"2013","journal-title":"Clin Obstet Gynecol"},{"key":"10.1016\/j.therap.2022.10.003_bib0560","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S0890-6238(01)00136-8","article-title":"Fetal effects of cocaine: an updated meta-analysis","volume":"15","author":"Addis","year":"2001","journal-title":"Reprod Toxicol"},{"key":"10.1016\/j.therap.2022.10.003_bib0565","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.ajog.2010.11.013","article-title":"Effects of cocaine use during pregnancy on low birthweight and preterm birth: systematic review and metaanalyses","volume":"204","author":"Gouin","year":"2011","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.therap.2022.10.003_bib0570","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1002\/tera.1420440407","article-title":"Relationship between gestational cocaine use and pregnancy outcome: a meta-analysis","volume":"44","author":"Lutiger","year":"1991","journal-title":"Teratology"},{"key":"10.1016\/j.therap.2022.10.003_bib0575","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1001\/archpedi.159.9.824","article-title":"Acute neonatal effects of cocaine exposure during pregnancy","volume":"159","author":"Bauer","year":"2005","journal-title":"Arch Pediatr Adolesc Med"},{"key":"10.1016\/j.therap.2022.10.003_bib0580","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1097\/EDE.0b013e31818e5930","article-title":"Maternal periconceptional illicit drug use and the risk of congenital malformations","volume":"20","author":"van Gelder","year":"2009","journal-title":"Epidemiology"},{"key":"10.1016\/j.therap.2022.10.003_bib0585","doi-asserted-by":"crossref","first-page":"e348","DOI":"10.1542\/peds.2006-1404","article-title":"Impact of prenatal cocaine exposure on child behavior problems through school age","volume":"119","author":"Bada","year":"2007","journal-title":"Pediatrics"},{"key":"10.1016\/j.therap.2022.10.003_bib0590","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1542\/peds.2009-0637","article-title":"A review of the effects of prenatal cocaine exposure among school-aged children","volume":"125","author":"Ackerman","year":"2010","journal-title":"Pediatrics"},{"key":"10.1016\/j.therap.2022.10.003_bib0595","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.drugalcdep.2017.01.027","article-title":"The association of prenatal cocaine exposure, externalizing behavior and adolescent substance use","volume":"176","author":"Minnes","year":"2017","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.therap.2022.10.003_bib0600","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.therap.2017.01.010","volume":"72","author":"Frauger","year":"2017","journal-title":"Therapie"},{"key":"10.1016\/j.therap.2022.10.003_bib0605","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1159\/000506630","article-title":"Primary care of opioid use disorder: the end of \u201cthe French model\u201d?","volume":"26","author":"Dupouy","year":"2020","journal-title":"Eur Addict Res"},{"key":"10.1016\/j.therap.2022.10.003_bib0610","doi-asserted-by":"crossref","DOI":"10.3399\/bjgpopen20X101014","article-title":"Combatting the misuse of benzodiazepines and related Z drugs in French general practice: a clinical review","volume":"4","author":"Gentile","year":"2020","journal-title":"BJGP Open"},{"key":"10.1016\/j.therap.2022.10.003_bib0615","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1111\/fcp.12738","article-title":"Antidepressants abuse in subjects with opioid use disorders: a 10-year study in the French OPPIDUM program","volume":"36","author":"Dumonceau","year":"2022","journal-title":"Fundam Clin Pharmacol"},{"key":"10.1016\/j.therap.2022.10.003_bib0620","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0740-5472(01)00179-9","article-title":"A randomized controlled trial of brief cognitive-behavioral interventions for cannabis use disorder","volume":"21","author":"Copeland","year":"2001","journal-title":"J Subst Abuse Treat"},{"key":"10.1016\/j.therap.2022.10.003_bib0625","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0376-8716(00)00136-8","article-title":"The effectiveness of two intensities of psychosocial treatment for cocaine dependence","volume":"61","author":"Coviello","year":"2001","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.therap.2022.10.003_bib0630","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD005336.pub4","article-title":"Psychosocial interventions for cannabis use disorder","author":"Gates","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.therap.2022.10.003_bib0635","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1038\/npp.2017.212","article-title":"The current state of pharmacological treatments for cannabis use disorder and withdrawal","volume":"43","author":"Brezing","year":"2018","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.therap.2022.10.003_bib0640","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aax1532","article-title":"The treatment of cocaine use disorder","volume":"5","author":"Kampman","year":"2019","journal-title":"Sci Adv"}],"container-title":["Therapies"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0040595722001718?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0040595722001718?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T18:56:06Z","timestamp":1758567366000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0040595722001718"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":64,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["S0040595722001718"],"URL":"https:\/\/doi.org\/10.1016\/j.therap.2022.10.003","relation":{},"ISSN":["0040-5957"],"issn-type":[{"value":"0040-5957","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Increase of cannabis and cocaine use by pregnant women in France from 2005 to 2018: Insights of the annual cross sectional OPPIDUM survey","name":"articletitle","label":"Article Title"},{"value":"Therapies","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.therap.2022.10.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Soci\u00e9t\u00e9 fran\u00e7aise de pharmacologie et de th\u00e9rapeutique. Published by Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}